Status: Not yet recruiting
Ultra-early STatin in Patients With Aneurysmal subaRachnoid Hemorrhage (Ue-STAR)
A researcher-initiated and conducted multicenter, randomized controlled trial aimed at evaluating the efficacy and safety of ultra-early statin therapy in the treatment of acute aneurysmal subarachnoid hemorrhage (aSAH).
Participants needed: 522
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: The George InstituteUpdated: Sep 5, 2024Locations: 1
Eligibility criteria
Male or female; Aged ≥18 years [+2]
Treatment with statin prior SAH [+12]